Effect of thrombomodulin on plasminogen activation

Fibrinolysis and Proteolysis

Volumn 14, Issue 4, 2000, Pages 221-228

  Han, H S ^a   Wu, H L ^b   Lin, B T ^b   Shi, C S ^b   Shi, G Y ^b  

^a CHUNG HWA UNIVERSITY OF MEDICAL TECHNOLOGY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOMODULIN;

ARTICLE; BLOOD CHEMISTRY; ENZYME ACTIVATION; FIBRINOLYSIS; HUMAN; HUMAN CELL; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033864263     PISSN: 13690191     EISSN: None     Source Type: Journal    
DOI: 10.1054/fipr.2000.0059     Document Type: Article

References (51)

1. Collen D. On the regulation and control of fibrinolysis. Thromb Haemost 1980; 43: 77-89.
2. Mayer M. Biochemical and biological aspects of the plasminogen activation system. Clin Biochem 1990; 23: 197-211.
3. Hajjar KA. Cellular receptors in the regulation of plasmin generation. Thromb Haemost 1995; 74: 294-301.
4. Wu HL, Wu IS, Fang RY et al. The binding of plasminogen fragments to cultured human umbilical vein endothelial cells. Biochem Biophys Res Commun 1992; 188: 703-711.
5. Miles LA, Ginsberg MH, White JG, Plow EF. Plasminogen interacts with human platelets through two distinct mechanisms. J Clin Invest 1986; 77: 2001-2009.
6. Miles LA, Dahlberg CM, Plescia J, Felez J, Kato K, Plow EF. Role of cell-surface lysines in plasminogen binding to cells: identification of alpha-enolase as a candidate plasminogen receptor. Biochemistry 1991; 30: 1682-1691.
7. Kanalas JJ, Makker SP. Identification of the rat Heymann nephritis autoantigen (GP300) as a receptor site for plasminogen. J Biol Chem 1991; 266: 10825-10829.
8. Hembrough TA, Vasudevan J, Allietta MM, Glass IIWF, Gonias SL. A cytokeratin 8-like protein with plasminogen-binding activity is present on the external surfaces of hepatocytes, HepG2 cells and breast carcinoma cell lines. J Cell Sci 1995; 108: 1071-1082.
9. Hajjar KA, Jacovina AT, Chacko J. An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. J Biol Chem 1994; 269: 21191-21197.
10. Plow EF, Herren T, Redlitz A, Miles LA, Hoover-Plow JL. The cell biology of the plasminogen system. FASEB J 1995; 9: 939-945.
11. Sprengers ED, Kluft C. Plasminogen activator inhibitors. Blood 1987; 69: 381-387.
12. Lijnen HR, Collen D. In: Barrett AJ, Salvesen G (eds). Protease Inhibitors. Elsevier: Amsterdam, 1986; 457-476.
13. Edelberg JM, Pizzo SV. Kinetic analysis of the effects of heparin and lipoproteins on tissue plasminogen activator mediated plasminogen activation. Biochemistry 1990; 29: 5906-5911.
14. Esmon CT. The regulation of natural anticoagulant pathway. Science 1987; 235: 1348-1352.
15. Esmon CT, Esmon NL, Harris KW Complex formation between thrombin and thrombomodulin inhibits both thrombin-catalyzed fibrin formation and factor V activation. J Biol Chem 1982; 257: 7944-7947.
16. Esmon CT, Owen WG. Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. Proc Natl Acad Sci USA 1981; 78: 2249-2252.
17. Suzuki K, Kusumoto S, Deyashiki Y et al. Structure and expression of human TM, a thrombin receptor on endothelium acting as a cofactor for protein C activation. EMBO J 1987; 6: 1891-1897.
18. Suzuki K, Hayashi T, Nishioka J et al. A domain composed of epidermal growth factor-like structures of human TM is essential for thrombin binding and protein C activation. J Biol Chem 1989; 264: 4872-4876.
19. Zushi M, Gomi K, Yamamoto S, Maruyama I, Hayashi T, Suzuki K. The last three consecutive epidermal growth factor-like structures of human thrombomodulin comprise the minimum functional domain for protein C-activating cofactor activity and anticoagulant activity. J Biol Chem 1989; 264: 10351-10353.
20. Bourin MC, Ohlin AK, Lane DA, Stenfro J, Iindahl U. Relationship between anticoagulant activities and polyanionic properties of rabbit thrombomodulin. J Biol Chem 1988; 263: 8044-8052.
21. Honda G, Masaki C, Zushi M et al. The roles played by the D2 and D3 domains of recombinant human thrombomodulin in its function. J Biochem 1995; 118: 1030-1036.
22. Edelberg JM, Weissler M, Pizzo SV. Kinetic analysis of the effects of glycosaminoglycans and lipoproteins on urokinase-mediated plasminogen activation. Biochem J 1991; 276: 785-791.
23. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning, a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, 1989, Cold Spring Harbor, New York.
24. Shi GY, Hau JS, Wang SJ et al. Plasmin and the regulation of tissue-type plasminogen activator biosynthesis in human endothelial cells. J Biol Chem 1992; 267: 19363-19368.
25. Deutsch DG, Mertz ET. Plasminogen: purification from human plasma by affinity chromatography. Science 1970; 170: 1095-1096.
26. Brockway WJ, Castellino FJ. Measurement of the binding of antifibrinolytic amino acids to various plasminogen. Arch Biochem Biophys 1972; 151: 194-199.
27. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
28. Robbins KC, Summaria L. Plasminogen and plasmin. Methods Enzymol 1976; 45: 257-273.
29. Christensen U. C-terminal lysine residues of fibrinogen fragments essential for binding to plasminogen. FEBS Lett 1985; 182:43-46.
30. Milles LA, Dahlberg CM, Levin EG, Plow EF. Gangliosides interact directly with plasminogen and urokinase and may mediate binding of these fibrinolytic components to cells. Biochemistry 1989; 28: 9337-9343.
31. Stack MS, Johnson DA. Human mast cell tryptase activates single-chain urinary-type plasminogen activator (prourokinase). J Biol Chem 1994; 269: 9416-9419.
32. Ichinose A, Fujikawa K, Suyama T. The activation of pro-urokinase by plasma kallikrein and its inactivation by thrombin. J Biol Chem 1986; 261: 3486-3489.
33. de Munk GA, Groeneveld E, Rijken DC. Acceleration of the thrombin inactivation of single chain urokinase-type plasminogen activator (pro-urokinase) by thrombomodulin. J Clin Invest 1991; 88: 1680-1684.
34. Molinari A, Giorgetti C, Lansen J et al. Thrombomodulin is a cofactor for thrombin degradation of recombinant single-chain urokinase plasminogen activator "in vitro" and in a perfused rabbit heart model. Thromb Haemost 1992; 67: 226-232.
35. Suzuki K, Nishioka J, Hayashi T, Kosaka Y. Functionally active thrombomodulin is present in human platelets. J Biochem 1988; 104: 628-632.
36. Ogura M, Ito T, Maruyama I et al. Localization and biosynthesis of functional thrombomodulin in human megakaryocytes and a human megakaryoblastic cell line (MEG-01). Thromb Haemost 1990; 64: 297-301.
37. Lager DJ, Callaghan EJ, Worth SF, Raife TJ, Lentz SR. Cellular localization of thrombomodulin in human epithelium and squamous malignancies. Am J Pathol 1995; 146: 933-943.
38. Tamura A, Matsubara O, Hirokawa K, Aoki N. Detection of thrombomodulin in human lung cancer cells. Am J Pathol 1993; 142: 79-85.
39. Maruyama I, Bell CE, Majerus PW. Thrombomodulin is found on endothelium of arteries, veins, capillaries, and lymphatics, and on syncytiotrophoblast of human placenta. J Cell Biol 1985; 101: 363-371.
40. Soff G, Jackman R, Rosenberg R. Expression of thrombomodulin by smooth muscle cells in culture: different effects of tumor necrosis factor and cyclic adenosine monophosphate on thrombomodulin expression by endothelial cells and smooth muscle cells in culture. Blood 1991; 775: 515-518.
41. Raife TJ, Lager DJ, Madison KC et al. Thrombomodulin expression by human keratinocytes. J Clin Invest 1994; 93: 1846-1851.
42. Imada S, Yamaguchi H, Nagumo M, Katayanagi S, Iwasaki H, Imada M. Identification of fetomodulin, a surface marker protein of fetal development, as thrombomodulin by gene cloning and functional assays. Dev Biol 1990; 140: 113-122.
43. de Munk GA, Parkinson JF, Groeneveld E, Bang NU, Rijken DC. Role of the glycosaminoglycan component of thrombomodulin in its acceleration of the inactivation of single-chain urokinase-type plasminogen activator by thrombin. Biochem J 1993; 290: 655-659.
44. Dano K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, Skriver L. Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 1985; 44: 139-266.
45. Schmitt M, Janicke F, Graeff H. Tumor-associated proteases. Fibrinolysis 1992; 6: Suppl 4: 3-26.
46. Takebayashi Y, Yamada K, Maruyama I, Fujii R, Akiyama S, Aikou T. The expression of thymidine phosphorylase and thrombomodulin in human colorectal carcinomas. Cancer Letters 1995; 92: 1-7.
47. Collins CL, Ordonez NG, Schaefer R et al. Thrombomodulin expression in malignant pleural mesothelioma and pulmonary adenocarcinoma. Am J Pathol 1992; 141: 827-833.
48. Ordonez NG. Value of thrombomodulin immunostaining in the diagnosis of transitional cell carcinoma: a comparative study with carcinoembryonic antigen. Histopathology 1997; 31: 517-524.
49. Maruno M, Yoshimine T, Isaka T, Kuroda R, Ishii H, Hayakawa T. Expression of thrombomodulin in astrocytomas of various malignancy and in gliotic and normal brains. J Neuro-Oncology 1994; 19: 155-160.
50. Suehiro T, Shimada M, Matsumata T, Taketomi A, Yamamoto K, Sugimachi K. Thrombomodulin inhibits intrahepatic spread in human hepato-cellular carcinoma. Hepatology 1995; 21: 1285-1290.
51. Tezuka Y, Yonezswa S, Maruyama I et al. Expression of thrombomodulin in esophageal squamous cell carcinoma and its relationship to lymph node metastasis. Cancer Res 1995; 55: 4196-4200.